Notice of Application to Register a Trade Name Product (Notice No. MPI 1777)
Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register a trade name product under section 9(1) of the Act:
Trade Name: Redivom® 1 mg/mL Solution for Injection for Dogs
Registration Number: A012064
Active Ingredient and Concentration:
1mg/mL Apomorphine Hydrochloride Hemihydrate (equivalent to 0.85mg/mL Apomorphine)
Formulation Type: Aqueous solution for injection
Application Method/Administration Route:
For single subcutaneous use only. 0.1mg of apomorphine hydrochloride hemihydrate per kg bodyweight (1mL product per 10kg bodyweight).
Use Claim:
An emetic for use in dogs.
Apomorphine induces emesis by stimulation of the dopamine D2-receptors in the chemoreceptor trigger zone in the medulla oblongata. It should be noted that emesis should form part of a multi-modal treatment plan and the best treatment plan is to be determined by the veterinarian.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.
The following address is:
ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.
MPI encourages submission by email.
The applicant’s address for service is:
Dechra Veterinary Products NZ Limited, 198A Kapiti Road, Paraparaumu 5032. Postal Address: 2 Cal Close, Somersby, New South Wales 2250, Australia.
Dated at Wellington this 29th day of November 2023.
MAREE ZINZLEY, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).